At a time when recent clinical outcomes have highlighted the limits of GLP-1–based strategies in Alzheimer’s disease https://lnkd.in/drNryJvQ, the need for targeted, mechanism-driven interventions has never been clearer. The setback in #GLP-1 #Alzheimer’s trials reinforces a simple point: metabolic improvement alone is not enough to halt early neurodegenerative processes. Proud of this milestone and of the […]